MAP
JUNO

Moody Aldrich Partners’s Juno Therapeutics, Inc. JUNO Stock Holding History

Moody Aldrich Partners’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,461
Closed -$478K – 102
2017
Q4 		$478K Sell
10,461
-1,565
-13% -$78.1K 0.39% 80
2017
Q3 		$539K Buy
+12,026
New +$410K 0.55% 77

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Moody Aldrich Partners's JUNO Position: Q1 2018 in Review

Moody Aldrich Partners sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 10,461 shares — an estimated $478K sold.

Moody Aldrich Partners first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $539K in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Moody Aldrich Partners reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Moody Aldrich Partners sold 10,461 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $478K.
  • Moody Aldrich Partners first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Moody Aldrich Partners's Juno Therapeutics, Inc. position peaked at $539K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Moody Aldrich Partners's 13F filing for Q1 2018, filed 26 Apr 2018.